The task force shall do the following:
(1)Review and make recommendations concerning the cost of
health care in the state and in comparison to other states.
(2)Review and make recommendations concerning reductions in
health care costs with the goal of ensuring that any reduction in
health care prices ultimately reaches the health care payer.
(3)Review and make recommendations concerning reports
submitted to the task force.
(4)Study and make recommendations concerning the availability
of value-based care and other health care models that emphasize
prevention and cost avoidance.
(5)Study and make recommendations concerning the market
concentration of health care providers and contributing factors,
including:
(A)whether:
(i)noncompete clauses in practitioner contracts contributes
to a
Free access — add to your briefcase to read the full text and ask questions with AI
The task force shall do the following:
(1) Review and make recommendations concerning the cost of
health care in the state and in comparison to other states.
(2) Review and make recommendations concerning reductions in
health care costs with the goal of ensuring that any reduction in
health care prices ultimately reaches the health care payer.
(3) Review and make recommendations concerning reports
submitted to the task force.
(4) Study and make recommendations concerning the availability
of value-based care and other health care models that emphasize
prevention and cost avoidance.
(5) Study and make recommendations concerning the market
concentration of health care providers and contributing factors,
including:
(A) whether:
(i) noncompete clauses in practitioner contracts contributes
to a restraint of trade; and
(ii) prohibiting noncompete clauses would create greater
competition in the health workforce;
(B) contract tiering with health carriers;
(C) all-or-nothing network plans; and
(D) disclosure of cost and price information to plan sponsors.
(6) Study and make recommendations concerning whether
medical consumers would benefit from prohibiting
anti-competitive practices or otherwise encouraging increased
competition among providers.
(7) Study and make recommendations concerning whether
medical consumers overall would benefit from reestablishing the
former Indiana comprehensive health insurance association
policies (IC 27-8-10).
(8) Review and make recommendations concerning required
reporting for pharmacy benefit managers to the department of
insurance, including the report required under IC 27-1-24.5-21.
(9) Study and make recommendations concerning whether there
is sufficient competition in the commercial insurance market and
whether health care consumers would benefit from policies
designed to increase competition among commercial carriers,
including the promotion of:
(A) direct contracting;
(B) narrow networks; and
(C) insurance brokers.
(10) Study and make recommendations concerning whether there
is sufficient innovation in the design of health insurance plans,
including whether health care consumers would benefit from
policies that:
(A) better distinguish wellness and prevention from
comprehensive and catastrophic coverage;
(B) promote price discounts based on individual underwriting;
and
(C) empower the health care consumer with a focus on
prevention and shoppable services.
(11) Any other topic the task force deems relevant to the oversight
of health care costs in Indiana.